COVID-19, Immuno-oncology and Cardiovascular Disease: Viewpoint from the Intersection.

Siddiqi, Hasan K; Neilan, Tomas G

Siddiqi, Hasan K; Neilan, Tomas G.

Siddiqi HK; Divisions of Cardiovascular and Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Neilan TG; Cardio-Oncology Program, Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. TNEILAN@mgh.harvard.edu.

J Cardiovasc Transl Res ; 13(3): 347-348, 2020 06.

Article in English | MEDLINE | ID: covidwho-165283

Subject(s)

Betacoronavirus; Cardiovascular Diseases/etiology; Cardiovascular Diseases/pathology; Coronavirus Infections/complications; Pneumonia, Viral/complications; COVID-19; Coronavirus Infections/immunology; Coronavirus Infections/pathology; Humans; Pandemics; Pneumonia, Viral/immunology; Pneumonia, Viral/pathology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Cardiovascular Diseases / Coronavirus Infections / Betacoronavirus Topics: Long Covid Limits: Humans Language: English Journal: J Cardiovasc Transl Res Journal subject: Vascular Diseases / Cardiology Year: 2020 Document Type: Article Affiliation country: S12265-020-10013-8

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google